Delivery Order SPE2DR25D1053-SPE2DR26FV276
- Not listed
- The Defense Logistics Agency awarded a $11,653.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Gammagard Liquid 10% in 200ml vials, with an ultimate completion date of November 25, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for Gammagard Liquid 10% in 200ml vials, valued at $11,653.70. This non-competitive delivery order represents a firm fixed-price contract with an ultimate completion date of November 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a primary pharmaceutical distributor supporting federal medical procurement needs. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $34,961.10 to AmerisourceBergen Drug Corp for Gammagard Liquid 10% in 200mL vials, with an ultimate completion date of November 17, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $11,653.70 to AmerisourceBergen Drug Corp for Gammagard Liquid 10% in 200ml vials, with an ultimate completion date of November 25, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded on November 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical distribution...
- The Defense Logistics Agency awarded a delivery order valued at $136,505.52 to AmerisourceBergen Drug Corp for Gammagard Liquid 10% Vial 200ML, a critical immunoglobulin product used in military and federal healthcare systems. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by December 16, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at...
- The Defense Logistics Agency awarded a delivery order valued at $2,922.20 to AmerisourceBergen Drug Corp for Gammagard Liquid 10% vials (50mL) on November 14, 2025, with completion scheduled for December 8, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is performed at the contractor's facility in Conshohocken, Pennsylvania. Gammagard Liquid is an intravenous immunoglobulin (IVIG) therapy used for various immunodeficiency and autoimmune conditions,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,307.40 to AmerisourceBergen Drug Corp for the supply of Gammagard Liquid 10% in 200ML vials. The contract, awarded on November 4, 2025, with an ultimate completion date of November 26, 2025, operates under firm fixed pricing with no set-aside designation. This delivery order is a competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $34,961.10 on December 8, 2025, for Gammagard Liquid 10% in 200 mL vials. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award status. The contract is scheduled for completion by December 30, 2025, and performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Gammagard Liquid 10% in 200ml vials, with a ceiling value of $11,653.70 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of November 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $10,639.70 to AmerisourceBergen Drug Corp for Gammagard S-D 10 G on November 6, 2025, with an ultimate completion date of December 1, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV276Delivery Order
This delivery order, valued at approximately $29.7K with an ultimate completion date of January 28, 2026, awards AmerisourceBergen Drug Corp the supply of Gammagard Liquid 10% in 200mL vials to support federal healthcare operations. The award was made on a non-set-aside basis through firm fixed-price pricing by the Defense Logistics Agency, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., executes this delivery order under a significantly larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999.99M through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The Gammagard Liquid product supplied under this order represents a critical immunological therapeutic within AmerisourceBergen's extensive pharmaceutical portfolio delivered to federal military and healthcare systems. As a major pharmaceutical distributor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities, AmerisourceBergen leverages its prime vendor status to fulfill diverse medical supply requirements across multiple therapeutic domains. The non-competitive nature of this delivery order reflects the contractor's established position within DLA's pharmaceutical supply chain and its demonstrated capability to meet federal procurement standards for specialized medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.7k | 1/5/26 |